CBIO vs IOVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

CBIO

47.9
AI Score
VS
IOVA Wins

IOVA

60.6
AI Score

Investment Advisor Scores

CBIO

48score
Recommendation
HOLD

IOVA

61score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CBIO IOVA Winner
Revenue 1.04M 292.21M IOVA
Net Income -48.12M -148.63M CBIO
Net Margin -4631.4% -50.9% IOVA
Operating Income -51.09M -156.92M CBIO
ROE -29.5% -18.3% IOVA
ROA -26.3% -15.0% IOVA
Total Assets 182.76M 991.21M IOVA
Cash 171.59M 57.93M CBIO
Current Ratio 9.66 5.20 CBIO
Free Cash Flow -28.56M -154.17M CBIO

Relative Price Performance (Last 90 Days)

CBIO 1M: -3.7% · 3M: -15.3% IOVA 1M: -44.5% · 3M: +20.0%

Current Technical Phase

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.6 · Price: $13.92

IOVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 34

RSI (14): 33.6 · Price: $8.09

Fundamentals Snapshot

Metric CBIO IOVA
Market Cap — —
Forward P/E -5.3 -54.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.8%
Gross Margin 1.0% 0.5%
Operating Margin -14.3% -0.2%
EPS -7.63 -0.49
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IOVA is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.